Malte Lenders

2.2k total citations
63 papers, 1.5k citations indexed

About

Malte Lenders is a scholar working on Physiology, Epidemiology and Organic Chemistry. According to data from OpenAlex, Malte Lenders has authored 63 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Physiology, 27 papers in Epidemiology and 16 papers in Organic Chemistry. Recurrent topics in Malte Lenders's work include Lysosomal Storage Disorders Research (46 papers), Trypanosoma species research and implications (27 papers) and Carbohydrate Chemistry and Synthesis (15 papers). Malte Lenders is often cited by papers focused on Lysosomal Storage Disorders Research (46 papers), Trypanosoma species research and implications (27 papers) and Carbohydrate Chemistry and Synthesis (15 papers). Malte Lenders collaborates with scholars based in Germany, United States and Austria. Malte Lenders's co-authors include Eva Brand, Stefan‐Martin Brand, Boris Schmitz, Thomas Duning, Jörg Stypmann, Christian Schulze Gronover, Andrea Hillebrand, Dirk Prüfer, Christoph Wanner and Sima Canaan–Kühl and has published in prestigious journals such as Gastroenterology, PLoS ONE and Neurology.

In The Last Decade

Malte Lenders

61 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Malte Lenders Germany 24 970 538 474 384 293 63 1.5k
Verena Peters Germany 28 817 0.8× 722 1.3× 72 0.2× 618 1.6× 258 0.9× 81 1.8k
Zhenji Gan China 21 538 0.6× 1.1k 2.1× 215 0.5× 86 0.2× 179 0.6× 38 1.7k
Serena Grossi Italy 20 336 0.3× 730 1.4× 150 0.3× 72 0.2× 169 0.6× 33 1.2k
María Andrea Desbats Italy 21 421 0.4× 1.8k 3.3× 175 0.4× 30 0.1× 190 0.6× 28 2.2k
Kanako Sugawara Japan 15 389 0.4× 292 0.5× 190 0.4× 148 0.4× 138 0.5× 26 828
Sergio Muñoz Spain 18 728 0.8× 561 1.0× 397 0.8× 32 0.1× 98 0.3× 31 1.4k
Birgitte Ursø Denmark 20 342 0.4× 769 1.4× 87 0.2× 105 0.3× 409 1.4× 25 1.6k
Ying Lei China 21 288 0.3× 832 1.5× 65 0.1× 52 0.1× 145 0.5× 63 1.5k
Manuel Oropesa-Ávila Spain 16 210 0.2× 690 1.3× 237 0.5× 53 0.1× 128 0.4× 21 1.0k
M.G. Chambers United States 21 201 0.2× 952 1.8× 71 0.1× 73 0.2× 145 0.5× 46 2.6k

Countries citing papers authored by Malte Lenders

Since Specialization
Citations

This map shows the geographic impact of Malte Lenders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malte Lenders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malte Lenders more than expected).

Fields of papers citing papers by Malte Lenders

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malte Lenders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malte Lenders. The network helps show where Malte Lenders may publish in the future.

Co-authorship network of co-authors of Malte Lenders

This figure shows the co-authorship network connecting the top 25 collaborators of Malte Lenders. A scholar is included among the top collaborators of Malte Lenders based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malte Lenders. Malte Lenders is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Živná, Martina, Malte Lenders, & Stanislav Kmoch. (2025). Lysosomal Storage-Independent Fabry Disease Variants with α-Galactosidase A Misprocessing-Induced ER Stress and the Unfolded Protein Response. ˜The œNephron journals/Nephron journals. 149(10). 580–590. 1 indexed citations
2.
Lenders, Malte, Albina Nowak, Markus Cybulla, et al.. (2024). Impact of enzyme replacement therapy on clinical manifestations in females with Fabry disease. Orphanet Journal of Rare Diseases. 19(1). 490–490. 4 indexed citations
3.
Lenders, Malte, et al.. (2024). Biochemical Amenability in Fabry Patients Under Chaperone Therapy—How and When to Test?. BioDrugs. 38(6). 845–854. 1 indexed citations
4.
Lenders, Malte, et al.. (2023). Characterization of pre-existing anti-PEG and anti-AGAL antibodies towards PRX-102 in patients with Fabry disease. Frontiers in Immunology. 14. 1266082–1266082. 6 indexed citations
5.
Lenders, Malte & Eva Brand. (2022). Assessment and impact of dose escalation on anti-drug antibodies in Fabry disease. Frontiers in Immunology. 13. 1024963–1024963. 7 indexed citations
6.
Jehn, U., Veerle Van Marck, Thomas Weide, et al.. (2021). α-Galactosidase a Deficiency in Fabry Disease Leads to Extensive Dysregulated Cellular Signaling Pathways in Human Podocytes. International Journal of Molecular Sciences. 22(21). 11339–11339. 19 indexed citations
7.
Lenders, Malte & Eva Brand. (2021). Fabry Disease: The Current Treatment Landscape. Drugs. 81(6). 635–645. 86 indexed citations
8.
Krämer, Julia, Martin Hasselblatt, Eva Brand, et al.. (2020). Case Report: A Spinal Ischemic Lesion in a 24-Year-Old Patient With Fabry Disease. Frontiers in Immunology. 11. 595514–595514. 1 indexed citations
9.
Lenders, Malte, et al.. (2020). In Vitro and In Vivo Amenability to Migalastat in Fabry Disease. Molecular Therapy — Methods & Clinical Development. 19. 24–34. 31 indexed citations
10.
Lenders, Malte, et al.. (2020). CRISPR/Cas9-mediated correction of mutated copper transporter ATP7B. PLoS ONE. 15(9). e0239411–e0239411. 16 indexed citations
11.
Schmitz, Boris, Marcus E. Kleber, Malte Lenders, et al.. (2019). Genome-wide association study suggests impact of chromosome 10 rs139401390 on kidney function in patients with coronary artery disease. Scientific Reports. 9(1). 2750–2750. 1 indexed citations
12.
Xiao, Ke, Dongchao Lu, Laura Santer, et al.. (2019). Circulating microRNAs in Fabry Disease. Scientific Reports. 9(1). 15277–15277. 23 indexed citations
13.
Schmitz, Boris, et al.. (2018). ZFP226 is a novel artificial transcription factor for selective activation of tumor suppressor KIBRA. Scientific Reports. 8(1). 4230–4230. 4 indexed citations
14.
Schmitz, Boris, L. Thorwesten, Malte Lenders, et al.. (2017). Dose-Response of High-Intensity Training (HIT) on Atheroprotective miRNA-126 Levels. Frontiers in Physiology. 8. 349–349. 33 indexed citations
15.
Lenders, Malte, Frank Weidemann, Christine Kurschat, et al.. (2016). Alpha-Galactosidase A p.A143T, a non-Fabry disease-causing variant. Orphanet Journal of Rare Diseases. 11(1). 54–54. 48 indexed citations
16.
Lenders, Malte, Julia B. Hennermann, Christine Kurschat, et al.. (2016). Multicenter Female Fabry Study (MFFS) - clinical survey on current treatment of females with Fabry disease. Orphanet Journal of Rare Diseases. 11(1). 88–88. 36 indexed citations
17.
Lenders, Malte, Boris Schmitz, Bernd Kasprzak, et al.. (2015). Differential response to endothelial epithelial sodium channel inhibition ex vivo correlates with arterial stiffness in humans. Journal of Hypertension. 33(12). 2455–2462. 15 indexed citations
18.
Lenders, Malte, Sima Canaan–Kühl, Johannes Krämer, et al.. (2015). Patients with Fabry Disease after Enzyme Replacement Therapy Dose Reduction and Switch–2-Year Follow-Up. Journal of the American Society of Nephrology. 27(3). 952–962. 41 indexed citations
19.
Schmidt, Thomas J., Malte Lenders, Andrea Hillebrand, et al.. (2010). Characterization of rubber particles and rubber chain elongation in Taraxacum koksaghyz. BMC Biochemistry. 11(1). 11–11. 93 indexed citations
20.
Six, Jan, Malte Lenders, M. Vandermeeren, et al.. (1992). Neurite sprouting and cytoskeletal pathology in Alzheimer's disease: a comparative study with monoclonal antibodies to growth associated protein B-50 and paired helical filaments. 1. 247–255. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026